atropine has been researched along with Myopia, Pathological in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 15 (65.22) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LJ; Kam, KW; Ko, ST; Li, FF; Pang, CP; Tang, SM; Tham, CC; Wang, YM; Yam, JC; Yip, BHK; Young, AL; Zhang, XJ; Zhang, Y | 1 |
| Bai, Y; Cui, C; Fu, A; Li, X; Lyu, Y; Rong, J; Wei, L; Yu, S; Zhao, B | 1 |
| Chaurasia, S; Dogra, MR; Kaushik, S; Kishore, P; Kumar, A; Negi, S; Optom, RKM; Raj, S | 1 |
| De Zeeuw, CI; Hamelink, R; Klaver, CCW; Meester-Smoor, MA; Polling, JR; Tan, E; Thiadens, AAHJ; Tideman, JWL; van der Sande, E; Verhoeven, VJM; Willuhn, I; Winkelman, BHJ | 1 |
| Gao, S; Liu, X; Mu, Y; Xu, J; Yan, C; Yu, T; Zhang, L; Zhao, F | 1 |
| Adams, C; Allen, PM; Azuara-Blanco, A; Clarke, M; Congdon, N; Doherty, P; Flitcroft, I; Gardner, E; Hammond, C; Hogg, R; Lee, SS; Logan, N; Loughman, JJ; Mackey, DA; McFarland, M; Preston, J; Saunders, K; Strang, N; Verghis, R; Weir, R | 1 |
| Cotter, SA; Lindsley, KB; Mutti, DO; Ng, SM; Twelker, JD; Vedula, SS; Walline, JJ | 1 |
| Chen, LJ; Kam, KW; Ko, ST; Li, FF; Pang, CP; Tang, SM; Tham, CC; Yam, JC; Yip, BHK; Young, AL; Zhang, X | 1 |
| Cho, WH; Fang, PC; Huang, HM; Kuo, MT; Lin, PW; Yu, HJ | 1 |
| Driessen, S; Klaver, CCW; Loudon, SE; Polling, JR; Tan, E; Tideman, JWL; van der Schans, A; Wong, HL | 1 |
| An, W; Du, J; Li, SM; Liang, X; Sun, Y; Tian, J; Wang, N; Wei, S; Zhang, D | 1 |
| Cheng, SF; Liou, SW; Wang, YS; Wu, TE; Yu, TC | 1 |
| Chen, LJ; Kam, KW; Li, FF; Pang, CP; Tang, SM; Tham, CC; Yam, JC; Yip, BHK; Young, AL; Zhang, X; Zhang, Y | 1 |
| Fujikado, T; Hasebe, S; Hieda, O; Hiraoka, T; Ishiko, S; Kinoshita, S; Kurihara, T; Morimoto, T; Nakai, T; Nakamura, Y; Negishi, K; Nishi, Y; Nishida, K; Nishikawa, N; Ono, M; Oshika, T; Shigeno, Y; Song, YS; Sotozono, C; Takahashi, H; Tan, D; Tanaka, S; Tokutake, T; Torii, H; Tsubota, K | 1 |
| Graham, SL; Rose, LVT; Schulz, AM | 1 |
| Jain, R; Khadse, N; Kothari, M; Mutha, S; Rathod, V | 1 |
| Hoang, QV; Matsumura, S; Saw, SM | 1 |
| Wagner, RS | 1 |
| Kesarwani, SS | 1 |
| Bonsignore, F; Luccarelli, S; Nucci, P; Sacchi, M; Serafino, M; Tagliabue, E; Villani, E | 1 |
| Klaver, CC; Kok, RG; Meskat, B; Polling, JR; Tideman, JW | 1 |
| Davidson, SL; O'Hara, M; Wagner, RS | 1 |
| Chen, HM; Hsiao, CK; Tsai, MY | 1 |
2 review(s) available for atropine and Myopia, Pathological
| Article | Year |
|---|---|
Interventions to slow progression of myopia in children.
Topics: Atropine; Child; Contact Lenses; Cyclopentolate; Humans; Muscarinic Antagonists; Myopia, Degenerative; Ophthalmic Solutions; Pirenzepine; Randomized Controlled Trials as Topic | 2020 |
Consensus statement and guidelines for use of dilute atropine sulphate in myopia control.
Topics: Atropine; Consensus; Disease Progression; Humans; Mydriatics; Myopia, Degenerative; Ophthalmic Solutions; Practice Guidelines as Topic; Refraction, Ocular; Treatment Outcome | 2019 |
8 trial(s) available for atropine and Myopia, Pathological
| Article | Year |
|---|---|
Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout: Phase 3 Report.
Topics: Atropine; Axial Length, Eye; Child; Child, Preschool; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia, Degenerative; Refraction, Ocular; Sickness Impact Profile; Treatment Outcome; Visual Acuity | 2022 |
Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial.
Topics: Atropine; Case-Control Studies; Child; Disease Management; Female; Humans; Male; Mydriatics; Myopia, Degenerative; Refraction, Ocular; Treatment Outcome | 2021 |
Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population.
Topics: Adolescent; Atropine; Child; Dose-Response Relationship, Drug; Humans; Myopia, Degenerative; Ophthalmic Solutions; Prospective Studies; Treatment Outcome | 2022 |
Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol.
Topics: Administration, Ophthalmic; Atropine; Biometry; Child; Double-Blind Method; Female; Humans; Male; Mydriatics; Myopia, Degenerative; Ophthalmic Solutions; Refraction, Ocular; Surveys and Questionnaires; Treatment Outcome; United Kingdom; Visual Acuity | 2020 |
Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
Topics: Accommodation, Ocular; Administration, Topical; Atropine; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia, Degenerative; Ophthalmic Solutions; Refraction, Ocular; Time Factors; Visual Acuity | 2020 |
Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
Topics: Accommodation, Ocular; Atropine; Axial Length, Eye; Child; China; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Male; Mydriatics; Myopia, Degenerative; Ophthalmic Solutions; Refraction, Ocular; Retrospective Studies; Treatment Outcome; Visual Acuity | 2020 |
Age Effect on Treatment Responses to 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
Topics: Administration, Ophthalmic; Age Factors; Atropine; Axial Length, Eye; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Mydriatics; Myopia, Degenerative; Ophthalmic Solutions; Refraction, Ocular; Surveys and Questionnaires; Treatment Outcome; Visual Acuity | 2021 |
Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.
Topics: Accommodation, Ocular; Atropine; Child; Disease Progression; Humans; Myopia, Degenerative; Ophthalmic Solutions; Refraction, Ocular; Visual Acuity | 2021 |
13 other study(ies) available for atropine and Myopia, Pathological
| Article | Year |
|---|---|
Myopia control in Mendelian forms of myopia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atropine; Disease Progression; Female; Humans; Male; Mice; Mice, Inbred C57BL; Myopia, Degenerative; Ophthalmic Solutions; Refraction, Ocular; Retina | 2023 |
Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report.
Topics: Adolescent; Atropine; Axial Length, Eye; Child; Eye Abnormalities; Female; Humans; Myopia, Degenerative; Ophthalmologic Surgical Procedures; Refraction, Ocular | 2023 |
Analysis of tear film spatial instability for pediatric myopia under treatment.
Topics: Atropine; Bronchodilator Agents; Child; Cornea; Corneal Topography; Female; Humans; Male; Myopia, Degenerative; Orthokeratologic Procedures; Refraction, Ocular; Taiwan; Tears; Vision, Ocular; Visual Acuity | 2020 |
A 3-year follow-up study of atropine treatment for progressive myopia in Europeans.
Topics: Adult; Atropine; Child; Disease Progression; Follow-Up Studies; Humans; Myopia, Degenerative; Ophthalmic Solutions; Prospective Studies; Refraction, Ocular | 2020 |
A STROBE-compliant case-control study: Effects of cumulative doses of topical atropine on intraocular pressure and myopia progression.
Topics: Atropine; Case-Control Studies; Child; Female; Glaucoma; Humans; Intraocular Pressure; Longitudinal Studies; Male; Muscarinic Antagonists; Myopia, Degenerative; Ophthalmic Solutions; Prospective Studies; Tonometry, Ocular | 2020 |
Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01.
Topics: Atropine; Child; Disease Progression; Humans; Mydriatics; Myopia, Degenerative; Refraction, Ocular | 2021 |
Allergic reactions to atropine eye drops for retardation of progressive myopia in children.
Topics: Adolescent; Atropine; Child; Child, Preschool; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Humans; Male; Mydriatics; Myopia, Degenerative; Ophthalmic Solutions | 2018 |
Prevention and Management of Myopia and Myopic Pathology.
Topics: Atropine; Blindness; Contact Lenses, Hydrophilic; Cross-Linking Reagents; Disease Progression; Humans; Muscarinic Antagonists; Myopia; Myopia, Degenerative; Ophthalmologic Surgical Procedures; Orthokeratologic Procedures | 2019 |
Treatment of Progressive Myopia in the Pediatric Population.
Topics: Atropine; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Global Health; Humans; Incidence; Mydriatics; Myopia, Degenerative; Ophthalmic Solutions; Refraction, Ocular | 2019 |
Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients.
Topics: Adolescent; Atropine; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Italy; Male; Mydriatics; Myopia, Degenerative; Ophthalmic Solutions; Prevalence; Refraction, Ocular; Retrospective Studies; Treatment Outcome | 2019 |
Effectiveness study of atropine for progressive myopia in Europeans.
Topics: Administration, Topical; Adolescent; Atropine; Axial Length, Eye; Child; Disease Progression; Female; Humans; Male; Medication Adherence; Muscarinic Antagonists; Myopia, Degenerative; Netherlands; Ophthalmic Solutions; Refraction, Ocular; Treatment Outcome; White People | 2016 |
Management of Progressive Myopia.
Topics: Atropine; Computer Terminals; Contact Lenses; Disease Management; Eyeglasses; Humans; Mydriatics; Myopia, Degenerative; Orthokeratologic Procedures; United States | 2016 |
Inference of nested variance components in a longitudinal myopia intervention trial.
Topics: Analysis of Variance; Atropine; Child; Computer Simulation; Double-Blind Method; Eyeglasses; Female; Humans; Longitudinal Studies; Male; Models, Statistical; Mydriatics; Myopia, Degenerative; Randomized Controlled Trials as Topic | 2005 |